0      0


JL1128ES - JL1128ES: Real-world Treatment Patterns and Effectiveness of Palbociclib Plus an Aromatase Inhibitor (AI) in Patients With Metastatic Breast Cancer (MBC) Aged 75 or Above


‐ Oct 25, 2023 4:00pm

Full author listing

Adam Brufsky, MD, PhD (1); Xianchen Liu MD, PhD2; Benjamin Li, PhD2; Lynn McRoy, MD (2); Connie Chen,PharmD2; Rachel M. Layman, MD (3); Hope S. Rugo, MD (4)

1) UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, PA, USA; 2) Pfizer Inc., New York, NY, USA; 3) The University of Texas MD Anderson Cancer Center, Houston, TX, USA; 4)  University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA


Presenter(s):

You must be logged in and own this session in order to post comments.